# Bed Bath & Beyond Inc. (BBBY) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Consumer Cyclical / Specialty Retail. Price $4.35, market value $415 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Bed Bath & Beyond Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 0.4×**. Each dollar of revenue is priced at 0.4×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 1.7×**. The shares trade at 1.7× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: -19.5%** (5-yr avg -21.1%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Gross margin: 25.3%**. Bed Bath & Beyond Inc. keeps 25.3% of revenue after the direct cost of what it sells.
- **Operating margin: -7.6%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -8.1%**. The company reported a net loss over the last twelve months.
- **Return on equity: -38.9%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -118.5%**. Return on all capital, debt included, is -118.5%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -19.1%**. Each dollar of assets produces -19.1% of profit.

## Growth
- **Revenue growth (1 yr): -25.1%** (3-yr -18.5%/yr, 5-yr -16.0%/yr). Revenue fell 25.1% over the last year, against -16.0% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 74.6%**. Earnings per share rose 74.6%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.07**. Debt is 0.07 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 2.3×**. It would take 2.3 years of operating earnings to repay net borrowings, within the comfortable range.
- **Altman Z-score: 3.90**. A Z-score of 3.90 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Bed Bath & Beyond Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: buy** (4 analysts). 4 analysts cover Bed Bath & Beyond Inc.; the consensus is buy, with an average price target of $10.25 (+136% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -51.9%** (YTD -20.3%, 3-mo -4.8%). The shares are down 51.9% over twelve months including dividends.
- **From 52-week high: -65.6%** (6.4% above the low). Trading 66% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 39**. An RSI of 39 is neutral.
- **Beta (1 yr): 2.61** (volatility 77%). Beta of 2.61 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=BBBY · Page: https://foliofundamentals.com/stocks/bbby

Not investment advice.